BALCO Medical Centre Strengthens Advanced Cancer Care in Central India
4th February 2026
- Nearly 65,000 patients treated in eight years, underscoring the Centre’s clinical strength and commitment to accessible, affordable cancer care.
New Delhi, 3rd February, 2026: Ahead of World Cancer Day, Vedanta Limited, India’s leading metals, oil & gas, critical minerals, power and technology conglomerate, reaffirmed its commitment to strengthening India’s cancer care ecosystem through BALCO Medical Centre (BMC), one of India’s leading cancer care hospitals with a state-of-the-art 170-bed oncology facility in Raipur, Chhattisgarh, by expanding access to affordable, advanced and curative oncology care in central India.
Aligned with UN Sustainable Development Goal 3: Good Health and Well-Being, which aims to ensure healthy lives and promote well-being for all, BMC is bridging gaps in cancer care through advanced diagnostic and therapeutic capabilities. Since its inception in 2018, the Centre has emerged as a leading hub for comprehensive and accessible cancer treatment, having treated nearly 65,000 patients, performed close to 12,000 major surgeries, and delivered over 80,000 chemotherapy sessions. Beyond clinical care, BMC has conducted over 500 community health screening camps and cancer awareness programmes, reaffirming its sustained commitment to early detection and prevention across both rural and urban communities.
India carries a significant share of the global cancer burden, with many cases detected late and advanced care concentrated in metros. For non‑metro patients, limited access often means delayed treatment and poorer outcomes. Decentralised centres like BALCO Medical Centre help bridge this gap by bringing quality cancer care closer to communities.
Demonstrating this impact, BALCO Medical Centre recently performed one of the most challenging procedures in oncology, a Whipple pancreaticoduodenectomy with portal vein resection, on a 42-year-old patient diagnosed with borderline resectable pancreatic cancer. Procedures of this complexity are typically available only at a limited number of highly specialised centres worldwide.
Commenting on the significance of World Cancer Day, Ms. Jyoti Agarwal, Chairperson, Vedanta Medical Research Foundation, said, “World Cancer Day is a reminder that awareness, early detection and timely treatment are among the most effective tools we have to reduce the burden of cancer. Through BALCO Medical Centre and its community-focused interventions, we remain committed to expanding access to quality cancer care and encouraging a proactive approach to health. By taking preventive healthcare closer to communities, we aim to contribute meaningfully to a healthier and more resilient society.”
Reiterating the Centre’s focus on early diagnosis, Dr. Bhawna Sirohi, Medical Director, Vedanta Medical Research Foundation, said, “Early diagnosis and informed decision-making significantly improve cancer outcomes. Our initiatives on World Cancer Day reflect our dual focus on clinical excellence and community engagement. Through screenings, awareness programmes and expert-led interactions, we continue to empower individuals with the knowledge and support needed for timely intervention and a better quality of life.”
As part of its World Cancer Day initiatives, BMC organised multiple cancer screening camps across Chhattisgarh in collaboration with community organisations and educational institutions to identify risks early and encourage timely medical intervention, including the ‘Knowledge is Power’ cancer awareness webinar. To motivate individuals to prioritise preventive health measures, BMC also announced a limited period 20% concession on select health screening packages from 1-7 February 2026, helping reduce barriers to early diagnosis. Its on-ground outreach included screening programmes held with Terapanth Samaj, Raipur, a camp at Rungta Dental College, Bhilai, and a health talk and screening camp conducted in collaboration with State Health System Resource Centre (SHSRC) and Dear Foundation, Switzerland.
The first flagship initiative of the Vedanta Medical Research Foundation (VMRF), BALCO Medical Centre is improving access to quality medical care and making a meaningful difference in the lives of lakhs of people. BMC’s team of renowned cancer specialists regularly conducts awareness initiatives to educate individuals on the importance of timely preventive screening and early risk reduction for different types of cancer.
Medical experts from the centre engage with students, working professionals, and community members through platforms such as awareness talks, health camps, and webinars. In addition to cancer treatment, patients at BALCO Medical Centre receive comprehensive psychological, nutritional, and physical therapy support, along with access to patient support groups that provide emotional support throughout their care journey.
About Vedanta Limited:
Vedanta Limited, a subsidiary of Vedanta Resources Limited, is one of the world’s leading Oil & Gas and Metals company with significant operations in Oil & Gas, Zinc, Lead, Silver, Copper, Iron Ore, Steel, and Aluminium & Power across India, South Africa and Namibia. For two decades, Vedanta has been contributing significantly to nation building. Governance and sustainable development are at the core of Vedanta's strategy, with a strong focus on health, safety, and environment. Vedanta has put in place a comprehensive framework to be the ESG leader in the natural resources sector. Vedanta is committed to reducing carbon emissions to zero by 2050 or sooner and has pledged $5 billion over the next 10 years to accelerate the transition to net zero operations. Giving back is in the DNA of Vedanta, which is focused on enhancing the lives of local communities. The company’s flagship social impact program, Nand Ghars, have been set up as model anganwadis focused on eradicating child malnutrition, providing education, healthcare, and empowering women with skill development. Under the aegis of the Anil Agarwal Foundation, the umbrella entity for Vedanta’s social initiatives, the Vedanta group has pledged Rs 5000 crore over the next five years on social impact programmes with a thrust on nutrition, women & child development, healthcare, animal welfare, and grass-root level sports. Vedanta and the group companies have been featured in Dow Jones Sustainability Index, and was conferred Frost & Sullivan Sustainability Awards 2020, Golden Peacock Award for excellence in Corporate Governance 2022 and certified as a Great Place to Work 2022. Vedanta Limited is listed on the Bombay Stock Exchange and the National Stock Exchange.
For more information, please visit www.vedantalimited.com
About Vedanta Aluminium Business:
Vedanta Aluminium, a business of Vedanta Limited, is India’s largest producer of aluminium, manufacturing more than half of India’s aluminium i.e., 2.37 million tonnes in FY24. It is a leader in value-added aluminium products that find critical applications in core industries. Vedanta Aluminium ranks 1st in the S&P Global Corporate Sustainability Assessment 2023 world rankings for the aluminium industry, a reflection of its leading sustainable development practices. With its world-class aluminium smelters, alumina refinery and power plants in India, the company fulfils its mission of spurring emerging applications of aluminium as the ‘Metal of the Future’ for a greener tomorrow.
For more information, please log on to www.vedantaaluminium.com
Follow us on LinkedIN, Facebook, Twitter, Instagram
Disclaimer:
This press release contains “forward-looking statements” – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance, and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “should” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. For us, uncertainties arise from the behaviour of financial and metals markets including the London Metal Exchange, fluctuations in interest and or exchange rates and metal prices; from future integration of acquired businesses; and from numerous other matters of national, regional, and global scale, including those of a political, economic, business, competitive or regulatory nature. These uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.
